NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=140953&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Atkore Inc. (NYSE:ATKR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atkore-inc-lawsuit-submission-form?prid=140951&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/solaris-energy-infrastructure-inc-lawsuit-submission-form?prid=140948&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/venture-global-inc-lawsuit-submission-form?prid=140932&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sempra ("Sempra") (NYSE:SRE) concerning possible violations of federal securities laws. Before the market opened, Sempra released its fourth-quarter and full-year 2024 financial results on February 25, 2025, reporting annual revenue of $3.76 billion-falling $970 million short of consensus estimates.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals, Inc.") (NASDAQ:SUPN) concerning possible violations of federal securities laws. On February 19, 2025, The company announced that its Phase 2b study of SPN-820 for treatment-resistant depression failed to meet its primary endpoint, showing no significant improvement over placebo.

SAN FRANCISCO, CA, April 4, 2025 – PRISM MediaWire – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December

The Charles Schwab Co. NYSE: SCHW has evolved and grown from a tiny retail discount stockbroker on Wall Street in the financial services sector that gained prominence for its flat commission trades in the early 1990s to a retail financial services powerhouse with $10.28 trillion in assets in 2025. Despite the rough market backdrop plagued by recession risk and tariff fears, with the S&P 500 index trading down 5.2%, Schwab's stock is trading up 5.1% year-to-date (YTD) as of March 28, 2025.

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ultra Clean securities between May 6, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted 10 newly-hired employees restricted stock units (RSUs) covering an aggregate of 65,500 shares of BioCryst common stock. The RSUs were granted as of April 1, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces that it has closed the first tranche of its oversubscribed non-brokered private placement previously announced on March 24, 2025, raising aggregate gross proceeds of approximately US$3.08 million (the “Offering”).

Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer's disease agitation

New York, NY, April 04, 2025 (GLOBE NEWSWIRE) -- On April 2, 2025, Metal Sky Star Acquisition Corporation, a Cayman Islands exempted company, (“Metal Sky Star” or the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that (i) the Staff has determined that the Company's securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company's Ordinary Shares, Units, Rights, and Warrants will be suspended at the opening of business on April 9, 2025; and (iii) a Form 25-NSE will be filed with the Securities and …

Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights FY 2024 Revenue Increased 32.9% Year over Year Driven by Strategic Expansion and Operational Strength FY 2024 Direct Patient Services Revenue Increased 253.4% Year over Year Net …

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC.

GREENWICH, Conn., April 04, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) will hold its first quarter 2025 earnings conference call and webcast on Thursday, May 8, 2025, at 8:30 a.m. Eastern Time. The company's results will be released after market close on Wednesday, May 7, 2025, and made available at that time on www.investors.gxo.com.

HERZLIYA, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced that it will maintain current hardware pricing for U.S. customers, despite new tariffs imposed on imports to the United States. This decision underscores Nayax's commitment to customer growth and their operational excellence while showcasing the strength of its global operations.

BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 24th Annual Needham Virtual Healthcare Conference on Thursday, April 10th, at 8:45 am ET.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Skyworks Solutions, Inc. ("Skyworks" or "the Company") (NASDAQ:SWKS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Skyworks securities between July 30, 2024 and February 5, 2025, both dates inclusive (the "Class Period").